Steering Committee

  • Steering Committee

    • Gregory W. Randolph, MD, Co-Chair
    • Bryan McIver, MD , Endocrine Experts LLC, Co-Chair
    • Naifa Lamki Busaidy, MD
    • Ezra Cohen, MD
    • Jeremy Freeman, MD
    • Bryan Haugen, MD
    • Jatin P. Shah, MD
    • Ashok R. Shaha, MD
    • Steven I. Sherman, MD
    • Ian J. Witterick, MD

     

     

    Gregory W. Randolph, MD, FACS, FACE

    Dr. Gregory W. Randolph MD FACS FACE  is Full Professor of Otolaryngology Head and Neck Surgery and the Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology at Harvard Medical School. At Mass. Eye and Ear Infirmary he serves as the Director of both the General Otolaryngology and Thyroid and Parathyroid Endocrine Surgery Divisions and a member of the Mass. General Hospital Endocrine Surgical Service. He specializes exclusively in thyroid and parathyroid surgery. He serves as Chair elect of the American Head and Neck Society's Endocrine Surgery Section, Chair of the AACE Endocrine Surgery Committee and AACE Board Member and serves on the board of the International Thyroid Oncology Group.

    Dr. Randolph has focused the bulk of his research on recurrent laryngeal nerve anatomy, preservation and monitoring during thyroid cancer surgery with focus on importance of laryngeal exam, recognition of lymph node metastasis and revision cancer surgery and has over 155 peer reviewed publications. He has lead thyroid surgical missions to thyroid surgical units in St. Petersburg, Russia, Guangzhou, China, Kenya, rural India and in the Chernobyl region of the Ukraine. As a founding Steering Committee member of the World Congress on Thyroid Cancer (the largest thyroid cancer meeting in the world ) he is currently codirecting the 2017 World Congress in Boston He founded and directs the Harvard Thyroid and Parathyroid Surgery Course for surgeons and has directed international surgical courses in Italy, India, Germany, Switzerland and Russia. He has received board certification from the European Union’s Board of Surgery in Neck Endocrine Surgery. He has published an endocrine surgical text: “Surgery of the Thyroid and Parathyroid Glands” published by Elsevier Saunders now in its second edition as well as a text centered on surgery of the recurrent laryngeal nerve “The Recurrent and Superior Laryngeal Nerves” published by Theime Publishers. He was director of International Affairs for the American Academy of Otolaryngology Head and Neck Surgery served on their Board of Directors and currently is the Academy’s President. He has served as Treasurer and on the executive board of the American Thyroid Association. He currently serves as chair of the Endocrine Surgery Committees of the American Association of Clinical Endocrinology is chair –elect of the Endocrine Surgical Section of the American Head and Neck Society and is on the Board of Directors of the International Thyroid Oncology Group. He founded along with Dr. Henning Dralle of Germany the global International Neural Monitoring Study Group which has generated multiple publications and standards guidelines for neural monitoring at thyroid surgery.

     

     

    Bryan McIver, MD, PhD, FRCP (Edin)

    Dr. McIver received his MB ChB degree from the University of Edinburgh Medical School in Scotland, following undergraduate work in Edinburgh and a PhD in Physiology and Biophysics at the University of Vermont. He completed an Internal Medicine Residency at the Royal Infirmary of Edinburgh, followed by a Clinical Fellowship and Clinical Investigator Fellowship in Endocrinology at the Mayo Graduate School of Medicine in Rochester, MN.

    Dr. McIver joined the staff of Mayo Clinic in 1998 and spent 15 years as a Consultant in Endocrinology and Internal Medicine at the Mayo Clinic and Foundation, with 5 of those years as Chairman of the Mayo Clinic Thyroid Group. He was appointed as a founder member of the Endowed and Master Clinician Program at the Mayo Clinic in Rochester, Minnesota, in 2011, recognizing excellence in patient care.  In 2013, he moved to Moffitt Cancer Center, to become the Program Leader of the Endocrine Tumor Program.  His success in Leadership and team-building led to his appointment as Founding Chair of Moffitt’s newly created Department of Head and Neck, and Endocrine Oncology.  He additionally assumed the role of Interim Chair of the Department of Breast Oncology, pending recruitment of a new permanent Department Chair. Subsequently, in 2015, he was appointed Deputy Physician in Chief of the Moffitt Medical Group.

    Dr. McIver maintains an active busy practice, focused exclusively on patients with Thyroid Nodules and Thyroid Cancer; is active in research on molecular diagnostics, prognostics and therapeutics, and collaborates on clinical trial development in Thyroid Cancer, using targeted therapies, adaptive strategies and evolutionary principles; and he remains engaged in education of Fellows, Residents and Medical Students, having received two Mayo Clinic “Teacher of the Year” awards, recognizing his commitment to education.

    Dr McIver is a founding member of the World Congress on Thyroid Cancer, a quadrennial International meeting, now the largest such meeting in the World.  Amongst his most proud accomplishments was the creation of the Department of Head and Neck – Endocrine Oncology at Moffitt Cancer Center, now recognized as a World leader in the management of patients with thyroid cancer and other Endocrine malignancies.

     

     

    Naifa Lamki Busaidy, MD

    Naifa Busaidy’s clinical expertise and research interests are primarily focused driven to treat and improve outcomes in patients with aggressive thyroid and parathyroid carcinomas.   As an oncologic endocrinologist, I serve in various clinical trials as Principal Investigator and Co-Investigator where we identify the molecular mechanisms of disease progression and identify targets for improving response to therapy.

    My expertise coupled with well-established collaborators in a research environment that contains other funded investigators who are doing complementary research helps to assure that these research goals are accomplished.

     

     

    Ezra Cohen, MD

    Dr. Cohen is an internationally recognized expert on novel cancer therapies and heads the Solid Tumor Therapeutics program at Moores Cancer Center. His work focuses on squamous cell carcinomas and cancers of the thyroid, salivary gland and HPV-related oropharyngeal cancers.  He earned his medical degree from the University of Toronto, Ontario, Canada, completing his residencies in family medicine at the University of Toronto and in internal medicine at Albert Einstein College of Medicine.  Dr. Cohen completed his hematology/oncology fellowship at the University of Chicago, Pritzker School of Medicine where he was named chief fellow.  Prior to joining UC San Diego Health System, he was the co-director of the Head and Neck Cancer Program at the University of Chicago Comprehensive Cancer Center.  Dr. Cohen is a board-certified oncologist and cancer researcher.

     

     

    Jeremy Freeman, MD

    Dr. Jeremy Freeman attended medical school at the University of Toronto, graduating with highest honours. He completed his otolaryngology residency at the University of Toronto.

    After receiving his Fellowship from the Royal College of Surgeons of Canada in 1978, he spent two further years of advanced training, one as a Gordon Richards Fellow at the Princess Margaret Hospital in Toronto in Radiation and Medical Oncology and a second year as a McLaughlin Fellow, training in Head and Neck Oncology at the Royal Marsden Hospital in London, UK. He was the first fellow of the Advanced Training Council sponsored by the two head and neck societies.

    He has delivered over 500 scholarly addresses and published 280 articles in the scientific literature.

    He is on the editorial board of several high impact journals.

    He has trained hundreds of post graduate residents and 71 fellows.

    A Full Professor, he occupies the Temmy Latner/Dynacare Chair in Head and Neck Oncology at the University of Toronto, Faculty of Medicine.

    He has an active practice focusing on head and neck oncology with a primary interest in endocrine surgery of the head and neck.

     

     

    Bryan Haugen, MD

    Since finishing training at the University of Colorado Health Sciences Center in 1993, Dr. Haugen has been interested in the molecular mechanisms governing thyrotrope function and thyroid neoplasms.

    His current clinical interests include thyroid neoplasms, advanced thyroid cancer, thyroid dysfunction and other endocrine tumors (parathyroid, adrenal, carcinoid).  Dr Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets.

    Specific areas of research include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer, as well as proteomic approaches to molecular markers in thyroid neoplasms.  His research group is also actively studying novel regulation of the hypothalamic-pituitary-thyroid axis.

     

     

    Jatin P. Shah, MD

    Jatin P. Shah, M.D. is Professor of Surgery at Cornell University Medical College and holds The Elliott W. Strong Chair in Head and Neck Oncology at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. He graduated from MS University in Baroda, India, and trained in surgical oncology and Head and Neck Surgery at MSKCC.

    In addition to his superlative patient care, Dr. Shah is an international leader in the field of head and neck surgery. He has delivered over 1,200 scientific presentations worldwide, over 80 eponymous lectures, and published more than 550 peer reviewed articles and 10 medical textbooks.

    He has served as president of The New York Cancer Society, The New York Head and Neck Society, The Society of Head and Neck Surgeons, The North American Skull Base Society and the International Academy of Oral Oncology. He founded The International Federation of Head and Neck Oncologic Societies (IFHNOS), and serves as its CEO. He is listed amongst the Top Doctors in USA directories for 63 times in last 20 years.

    He was awarded Honorary Fellowships from The Royal College of Surgeons of Edinburgh, London and Australia, Honorary Ph.D. degrees from Belgium and Greece, Honorary D.Sc, from India, the Blokhin Gold Medal from Russia, the Janeway Medal from the The American Radium Society, and the Ellis Island Medal of Honor from the USA. In recognition of his outstanding achievements,  Dr. Shah has received numerous awards, including an eponymous lecture established  in his name by IFHNOS , an academic symposium in his name by the  American Head and Neck Society, and a Annual lectureship and  an endowed  chair in his name established by MSKCC.

     

     

    Ashok R. Shaha, MD

    Dr. Shaha is an Attending Surgeon on the Head and Neck Service at Memorial Sloan-Kettering Cancer Center, Jatin P. Shah Chair in Head and Neck Surgery, and Professor of Surgery at Cornell University Medical College, New York.  Dr. Shaha completed his surgical training at M.S. University of Baroda, India and worked as a House Surgeon at Tata Memorial Hospital, where he developed an interest in head and neck surgical oncology.

    After his arrival at Memorial Sloan-Kettering Cancer Center in 1975, Dr. Shaha did a surgical oncology fellowship and subsequently completed his surgical training at Downstate Medical Center in Brooklyn, New York.  Dr. Shaha returned to Memorial Hospital in 1981 as a Fellow in Head and Neck Surgery.

    He joined the Department of Surgery at Downstate Medical Center in 1982 as a Head and Neck Surgeon, rising to the rank of Professor of Surgery in 1992.  During this period, he was also Chief of Head and Neck Surgery at King’s County, Brooklyn VA Hospital and University Hospital.  From 1987 to 1989, Dr. Shaha spent two years as Acting Chief of Surgery at Brooklyn VA Medical Center.  In August of 1993, Dr. Shaha moved to Memorial Sloan-Kettering Cancer Center as an Attending Surgeon on the Head and Neck Service.

    During his post-graduate training, Dr. Shaha secured several gold medals and was given the Golden Apple Teaching Award at Downstate Medical Center.  Other awards Dr. Shaha received include: Faculty Member of the AOA Honor Medical Society, the Outstanding Teacher Award at Memorial Sloan-Kettering Cancer Center in 1996, the Honor Award from the American Academy of Otolaryngology/Head and Neck Surgery, and he was named Visiting Professor of the Society of Head and Neck Surgeons in 1997 and 1998.

    He has been honored by visiting professorships at University of Santa Tomas, Manila, and Sun Yat-Sen University Guang Zhou, China.  Dr. Shaha has been actively involved in local and national head and neck societies, as well as having been President of the New York Head and Neck Society, the American Society for Surgeons of Indian Origin, and the Brooklyn Surgical Society.  He was Co-President of the American Head and Neck Society, 1998-1999, and was President of the New York Cancer Society, 1999-2000 and President of the New York Surgical Society, 2004-2005.  He is a member of many scientific organizations and serves on the editorial board of the Journal of Surgical Oncology, Head and Neck, Annals of Surgical Oncology, Brazilian Journal of Surgery, and Journal of Clinical Oncology.

    He is an honorary member of the Brazilian College of Surgeons, the Cuban Surgical Society, Association of Surgeons of India, the Korean Head and Neck Society, Latin Head and Neck Society, Panamanian Society of Oncology, Chilean College of Surgeons, and Costa Rican Endocrine Society.  He has been a visiting professor at many universities throughout the United States, as well as a guest speaker in many South American, Asian and European countries.  He was the Program Chairman for the Fifth International Head and Neck Oncology Meeting in San Francisco (2000) and served as the Conference Chairman for the Sixth International Head and Neck Meeting in 2004.  Recently Dr. Shaha was the recipient of the Distinguished Service Award by the American Academy of Otolaryngology – Head and Neck Surgery; he was recently nominated as President of the American Association of Endocrine Surgeons.  Recently he was elected to the American Surgical Association.

    Dr. Shaha has been academically active at national and international meetings, with approximately 585 papers, 435 of which are peer-reviewed (PubMed and Scopus).  His Curriculum Vitae includes 140 published abstracts, 63 posters and 45 scientific exhibits presented.  His research interests include tracheal reconstruction and an experimental model of tracheomalacia and thyroid cancer.

    Dr. Shaha has dedicated his professional career to the training of medical students and residents and has developed a preceptorship program at Cornell University Medical College in head and neck training for medical students.  He is Chairman of the Advanced Training Council for Head and Neck Oncology Fellowships in the USA.

     

     

    Steven I. Sherman, MD

    Steven I. Sherman is Naguib Samaan Distinguished Professor and Chair of the Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, at The University of Texas MD Anderson Cancer Center.

    He received his medical degree from The Johns Hopkins School of Medicine, in Baltimore, Maryland, where he also completed his internship and residency in internal medicine and his fellowship in endocrinology and metabolism.  Dr. Sherman holds board certifications in internal medicine and endocrinology, diabetes, and metabolism.

    He is the director of the National Thyroid Cancer Treatment Cooperative Study Group, member of the Thyroid Cancer Panel of the National Comprehensive Cancer Network Guidelines Program, and Chairman of the International Thyroid Oncology Group.  Dr. Sherman’s current and past research has focused on the management of patients with differentiated and medullary thyroid carcinomas.

    He has emphasized two broad categories of research: what are the optimal uses of therapy and diagnostic monitoring for patients with low risk differentiated thyroid carcinomas, and what novel therapies can be used for patients with advanced thyroid carcinomas that are not responsive to more typical interventions.  Dr. Sherman is author or co-author on more than 100 peer reviewed publications.

     

     

     

    Ian Witterick, MD

    Ian Witterick is Professor and Chair of the Department of Otolaryngology-Head & Neck Surgery at the University of Toronto and Otolaryngologist-in-Chief at Sinai Health System in Toronto.  His clinical interests are head and neck oncology, rhinology and anterior skull base surgery. He is actively involved with national and international organizations related to otolaryngology and is currently President-Elect of the North American Skull Base Society and 2nd Vice-President of the Canadian Society of Otolaryngology-Head & Neck Surgery.

    Dr. Witterick is a member of the Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum and an Associate Editor for the Journal of Otolaryngology-Head & Neck Surgery and the American Journal of Rhinology & Allergy. He is a frequently invited speaker nationally and internationally and has published widely in the fields of head & neck oncology, rhinology, and skull base surgery.

    Dr. Witterick has received numerous teaching awards at the University of Toronto including the Postgraduate Medical Education Program Development and Innovation Award, the Charles Mickle Fellowship Award and the Colin R. Woolf Award for Long-Term Contributions in Continuing Education. In 2013 he received the Educational Excellence Award from the Canadian Society of Otolaryngology - Head and Neck Surgery. At the University of Toronto he chaired the Education Committee and is now Deputy Speaker for Faculty Council. At the Royal College of Physicians and Surgeons of Canada, he has been the Chief Examiner for otolaryngology-head & neck surgery, a member of the accreditation committee and currently is a member of the international accreditation committee.